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A s we age, the blood vessel becomes more susceptible topathologies including hypertension and atherosclerosis.
A famous saying of Thomas Sydenham, English physician,
states: “man is as old as his arteries.” However, changes in
the function and structure of the arteries with aging, such as
arterial stiffening and thickening, do not occur to the same
extent in all people. Studies by Seals et al strongly suggest
that habitual physical activity/aerobic exercise can slow or
prevent the aging of the blood vessels, as measured by
arterial compliance, even in previously sedentary middle-aged
and older adults.1–3 Exercise training is known to induce
several adaptations in the cardiovascular system, in part, by
increases in laminar blood flow.4 This, in turn, leads to
increased production of endothelial-derived nitric oxide (NO)
that is critical to the regulation of vascular responses,
including vascular tone and permeability, platelet adhesion
and aggregation, endothelial-leukocyte interactions, and vas-
cular smooth muscle cell proliferation.5 Therefore, it is not
surprising that NO has been touted as having an important
role in the architecture of the blood vessel. In this issue of
JAHA, Steppan and colleagues demonstrate that exercise
suppresses an age-associated increase in vascular transglu-
taminase activity and propose that this NO-mediated
effect contributes to exercise-induced arterial remodeling
and specifically the attenuation of age-associated vascular
stiffness.6
A major advance in the field of vascular biology research
was the development of methodologies to assess the elastic
properties of arteries in humans. The vasodilatory response to
acetylcholine has been a gold-standard method for evaluating
vascular relaxation with aging and exercise training. However,
the invasive nature of this measurement prevents it from
being widely used as a clinical diagnostic. Rather, the
determination of the pulse wave velocity (PWV) has been
used in the clinical setting as a noninvasive measurement of
the wave reflections occurring in the walls of the aorta. The
pressure waves move more rapidly in the stiffer aorta, and
therefore, high aortic PWV is an independent predictor of
arterial stiffness (compliance) as well as cardiovascular
morbidity and mortality.7 Although exercise is well known to
have beneficial effects on overall vascular health in aging
through enhancing local endothelial nitric oxide synthase
(eNOS) and NO release, less clear has been the molecular
mechanism linking exercise and enhanced NO production
with chronic improvements in vascular compliance.
Nitric oxide donors and endogenously produced NO exert a
variety of effects through the second messenger guanylate
cyclase, which in turn activates cyclic GMP.7,8 The effect of
NO, however, is not completely blocked by methylene blue, an
inhibitor of guanylate cyclase, suggesting that NO mediates
some benefits independent of cGMP.8,9 In fact, many of the
known effects of NO appear to be mediated by a chemical
modification of cysteine residues, termed S-nitrosylation, that
affects the function of many proteins.10 One of the proteins
regulated and nitrosylated by NO is tissue transglutaminase
(TG2). TG2 may represent an important link between endo-
thelial dysfunction, characterized by decreased NO bioavail-
ability, and long-term remodeling of the vascular wall,
especially of the large elastic arteries that influence pulse
wave velocity. Tissue transglutaminase has been demon-
strated previously to be produced by most cells of the
vascular wall including smooth muscle, endothelia, and
fibroblasts.11,12 Although TG2 has been demonstrated to play
a role intracellularly as a GTPase, it is the secretion of TG2 to
the extracellular matrix that appears to promote vascular
stiffness.13 An increase in TG2 activity promotes post-
translational modification of proteins through production of
an epsilon (gamma-glutamyl) lysine crosslink within the
adventitial and subendothelial layers of the vessel wall.14 A
recent study by Santhanam et al demonstrated a clear
increase in TG2 activity with age that was linked to increased
arterial stiffness.15 In addition, they demonstrated that
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treatment of rats with a TG inhibitor reduced the age-
associated increase in vascular stiffness. Collectively, these
observations suggest that TG2 may play an important role in
the process of vascular stiffening with aging.
The current study by Steppan et al in this edition of JAHA
added more insight regarding the regulatory role of TG2.6
They provide evidence that exercise-mediated NO suppresses
tissue TG2 activity to potentially prevent vascular aging/
stiffness. For these studies, they first evaluated the impact of
4 weeks of treadmill exercise in a small cohort of 20-month
old rats and found a modest attenuation of the TG2 activity in
the exercise-trained rats compared with the age-matched
sedentary control rats. However, despite this influence on TG2
activity, there was no improvement in the PWV, suggesting
that compliance was unchanged in these older animals. This
prompted the authors to speculate that the prevention of the
age-associated PWV changes may require a longer interven-
tion (14 weeks) in younger animals. Using 11-month-old rats
with age-matched and younger (6 months) sedentary rats as
controls, they observed restoration of phosphorylation at the
eNOS activating site (Ser1177), in the old exercise rats.
Moreover, increased phosphorylation of vasodilator-stimu-
lated phosphoprotein (VASP), a protein known to be regulated
in a cGMP-dependent manner, confirmed an increase in NO
production and NO/cGMP signaling by exercise in the old
rats. In addition, the TG crosslinking activity was elevated only
in the old sedentary group compared with the young controls.
The researchers attribute the increase in TG crosslinking
activity to suppression of NO bioavailability with aging.
Consistent with this, the examination of the aorta of the
old-trained, old-untrained, and young rats revealed that TG2
S-nitrosylation in the old exercise cohort was significantly
increased compared with the age-matched sedentary coun-
terparts and was comparable to the young sedentary controls.
The authors explain that altered TG2 function through
S-nitrosylation is due to an augmentation of NO production
by exercise. Mechanistic aortic tensile tests demonstrated
that aortic samples from the exercise-trained rats were
statistically more elastic compared with their sedentary
controls, despite the fact that the tensile properties of the
aorta in the older trained rats resemble that of the older
untrained when compared with the young rats.
These studies provide an exciting potential mechanistic
link between endothelial function and vascular remodeling
that may help explain observations made in those that are
regularly physically active. However, based on recent work by
this group, the suppression of vascular TG2 crosslinking
activity would be hypothesized to improve vascular compli-
ance following this prolonged period (14 weeks) of exercise
training. In this recent study, Santhanam and colleagues
reported significantly lower PWV following a 3-month treat-
ment of cystamin, a TG inhibitor, in older rats (22 to
24 months of age) compared with age-matched control rats
using single-point PWV.15 Nevertheless, although TG2 activity
was decreased by exercise in the current study, vascular
stiffness remained unchanged compared with their sedentary
counterparts. Moreover, in the current study, the authors
employed a more thorough evaluation of the vascular stiffness
by determining the PWV across a dynamic range of blood
pressures (from 50 to 200 mm Hg of systolic pressure)
through in vivo pharmacologic alterations with phenylephrine
and sodium nitroprusside. Their rationale for this more
invasive approach was that wall stiffness depends on blood
pressure, which, in turn, affects PWV. Therefore, by evaluating
the PWV across this dynamic blood pressure range they can
provide a more complete evaluation of vascular stiffness.
However, despite the collection of this thorough PWV profile,
no differences in vascular stiffness were evident between the
old-sedentary and old-trained cohorts. The authors suggest
that the accumulation of cross-linked collagen prior to the
initiation of the exercise regimen (at 11 months) may have
overshadowed the benefits of TG2 S-nitrosylation and
suppressed protein cross-linking during the 14-week exercise
training period.
Although Steppan and colleagues nicely characterize the
effect of moderate aerobic exercise on TG2 activity in the rat
model of aging, this interesting study prompts several
additional questions. A primary question that requires atten-
tion is whether the suppression of extracellular TG2 activity is
necessary for exercise-mediated improvements in age-asso-
ciated vascular stiffness. The authors have demonstrated
exercise to suppress vascular TG2 activity and to have a
modest improvement in elasticity in rats >1 year old.
However, the invasive and sophisticated measure of pulse-
wave velocity did not provide evidence of an exercise-
mediated improvement in the vascular stiffness of these older
animals. Does this result portend that exercise is incapable of
inducing a benefit in the setting of advanced vascular
stiffness? As the authors described in the limitation section
of their paper, an earlier initiation of exercise might have
suppressed the TG2-mediated cross-linking of adventitial
proteins. However, does this suggest that exercise can only
suppress further increases in stiffness rather than the reversal
of this cross-linking process? The evidence of improved
arterial compliance from human studies is rather limited.
Steppan et al caution that observed differences in the
traditional non-invasive measure of pulse wave velocity may
be due to improvements in blood pressure following exercise
training and not represent true improvements in vascular
stiffness.6 However, previous exercise studies by Tanaka
et al, using a more direct measure of arterial compliance,
resulted in significant reductions in arterial stiffness without
alterations in arterial blood pressure. These studies were
performed in middle-aged men and improvements were
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evident following only 3 months of aerobic exercise.1 There-
fore, there is some discrepancy between the animal and
human exercise studies regarding improvements in arterial
compliance. As stated by Steppan et al, future studies
investigating the importance of exercise intensity and the
impact of an earlier intervention are required.
Collectively, Steppan et al provide a novel mechanism to
explain how exercise-induced improvements in endothelial
function can directly lead to structural remodeling in the
vascular adventitia. The suppressed S-nitrosylation of TG2 in
older sedentary animals promotes an increase in tissue TG
activity and, with time, an increase in vascular stiffness.
However, the induction of NO with exercise promotes S-
nitrosylation of TG2 and thereby suppresses tissue TG activity.
These events can block the crosslinking of extracellular matrix
proteins andmay therefore attenuate the rigidity of the vascular
adventitia. Future studies will be needed to determine what
dose of exercise is optimal for maintaining healthy “young”
arteries and to ascertain if these molecular events regarding
TG2 are necessary to prevent age-associated vascular stiffness.
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